VR Logo

Dishman Carbogen Amcis Ltd. download report


Healthcare | Drugs & Pharma

Dishman Carbogen Amcis Ltd. Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

Financial Year Full AR Chairman's
Speech
Director's
Report
Management
Discussion
Corporate
Governance
Auditor's
Report
Notes to
Accounts
2021 Dishman Carbogen Amcis Ltd. Annual Report
2020 Dishman Carbogen Amcis Ltd. Annual Report Dishman Carbogen Amcis Ltd. chairman speech Dishman Carbogen Amcis Ltd. director's report Dishman Carbogen Amcis Ltd. management discussion Dishman Carbogen Amcis Ltd. corporate governance Dishman Carbogen Amcis Ltd. auditor's report Dishman Carbogen Amcis Ltd. account notes
2019 Dishman Carbogen Amcis Ltd. Annual Report Dishman Carbogen Amcis Ltd. chairman speech Dishman Carbogen Amcis Ltd. director's report Dishman Carbogen Amcis Ltd. management discussion Dishman Carbogen Amcis Ltd. corporate governance Dishman Carbogen Amcis Ltd. auditor's report Dishman Carbogen Amcis Ltd. account notes
2018 Dishman Carbogen Amcis Ltd. Annual Report Dishman Carbogen Amcis Ltd. chairman speech Dishman Carbogen Amcis Ltd. director's report Dishman Carbogen Amcis Ltd. management discussion Dishman Carbogen Amcis Ltd. corporate governance Dishman Carbogen Amcis Ltd. auditor's report Dishman Carbogen Amcis Ltd. account notes
2017 Dishman Carbogen Amcis Ltd. Annual Report Dishman Carbogen Amcis Ltd. chairman speech Dishman Carbogen Amcis Ltd. director's report Dishman Carbogen Amcis Ltd. management discussion Dishman Carbogen Amcis Ltd. corporate governance Dishman Carbogen Amcis Ltd. auditor's report Dishman Carbogen Amcis Ltd. account notes
2016 Dishman Carbogen Amcis Ltd. Annual Report Dishman Carbogen Amcis Ltd. chairman speech Dishman Carbogen Amcis Ltd. director's report Dishman Carbogen Amcis Ltd. management discussion Dishman Carbogen Amcis Ltd. corporate governance Dishman Carbogen Amcis Ltd. auditor's report Dishman Carbogen Amcis Ltd. account notes

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 2007

Chairman: Janmejay R Vyas

Managing Director: Arpit J Vyas

Group: Dishman Pharma

Listing: BSE: 540701, NSE: DCAL

Country: India

Headquarters: Ahmedabad, Gujarat

Website: www.dishmangroup.com

Key Facts

Market cap: ₹1,824.96 Cr

Revenue (TTM): ₹2,140.70 Cr

Earnings (TTM): ₹17.97 Cr

Cash: ₹464.62 Cr

Total Debt: ₹1,165.89 Cr

Promoters' ownership: 59.32%

Liquidity: High

52 Week range: ₹97.40 - 259.70

Face value: ₹2.00

Shares outstanding: 15,67,83,095

10 Years Aggregate:

  • CFO: ₹1,896.89 Cr
  • EBITDA: ₹2,216.85 Cr
  • Net Profit: ₹504.90 Cr

Stock Performance

Time Period Dishman Carbogen Amcis S&P BSE Healthcare S&P BSE Small Cap
YTD-42.12-17.06-15.29
1 month-2.10-1.40-5.42
3 months-38.44-10.77-13.05
1 Year-45.20-16.41-2.40
3 Years-18.8118.8820.34
5 Years--8.859.89
10 Years--12.1314.11
As on 04-Jul-2022
Year Dishman Carbogen Amcis S&P BSE Small Cap S&P BSE Healthcare
202141.7962.7720.87
202076.7032.1161.45
2019-63.80-6.85-3.55
2018-28.09-23.41-5.89